Go Pro
→ $40,000,000,000,000 (From American Alternative) (Ad)tc pixel Free ZJYL Stock Alerts

Jin Medical International (ZJYL) Competitors

Jin Medical International logo
$1.99 +0.01 (+0.51%)
Closing price 09/18/2026 04:00 PM Eastern
Extended Trading
$1.93 -0.06 (-3.02%)
As of 09/18/2026 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

ZJYL vs. DCTH, BWAY, TCMD, NPCE, and SGHT

Should you buy Jin Medical International stock or one of its competitors? Jin Medical International's main competitors and comparable companies include Delcath Systems (DCTH), Brainsway (BWAY), Tactile Systems Technology (TCMD), NeuroPace (NPCE), and Sight Sciences (SGHT). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Jin Medical International compare to Delcath Systems?

Delcath Systems (NASDAQ:DCTH) and Jin Medical International (NASDAQ:ZJYL) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, profitability, analyst recommendations, institutional ownership, earnings, valuation and dividends.

Delcath Systems currently has a consensus target price of $23.17, suggesting a potential upside of 43.80%. Given Delcath Systems' stronger consensus rating and higher possible upside, equities research analysts clearly believe Delcath Systems is more favorable than Jin Medical International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Delcath Systems
1 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.86
Jin Medical International
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Delcath Systems has higher revenue and earnings than Jin Medical International.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Delcath Systems$85.23M6.56$2.70M$0.011,611.00
Jin Medical International$20.69M7.54$1.19MN/AN/A

Delcath Systems has a beta of 0.57, indicating that its stock price is 43% less volatile than the broader market. Comparatively, Jin Medical International has a beta of 7.31, indicating that its stock price is 631% more volatile than the broader market.

61.1% of Delcath Systems shares are owned by institutional investors. 19.4% of Delcath Systems shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Delcath Systems has a net margin of 0.56% compared to Jin Medical International's net margin of 0.00%. Delcath Systems' return on equity of 0.46% beat Jin Medical International's return on equity.

Company Net Margins Return on Equity Return on Assets
Delcath Systems0.56% 0.46% 0.42%
Jin Medical International N/A N/A N/A

In the previous week, Delcath Systems had 1 more articles in the media than Jin Medical International. MarketBeat recorded 1 mentions for Delcath Systems and 0 mentions for Jin Medical International. Delcath Systems' average media sentiment score of 0.26 beat Jin Medical International's score of -0.25 indicating that Delcath Systems is being referred to more favorably in the media.

Company Overall Sentiment
Delcath Systems Neutral
Jin Medical International Neutral

Summary

Delcath Systems beats Jin Medical International on 13 of the 15 factors compared between the two stocks.

How does Jin Medical International compare to Brainsway?

Jin Medical International (NASDAQ:ZJYL) and Brainsway (NASDAQ:BWAY) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, institutional ownership, media sentiment, analyst recommendations, earnings, profitability, dividends and valuation.

In the previous week, Brainsway had 1 more articles in the media than Jin Medical International. MarketBeat recorded 1 mentions for Brainsway and 0 mentions for Jin Medical International. Brainsway's average media sentiment score of 0.88 beat Jin Medical International's score of -0.25 indicating that Brainsway is being referred to more favorably in the news media.

Company Overall Sentiment
Jin Medical International Neutral
Brainsway Positive

30.1% of Brainsway shares are owned by institutional investors. 19.0% of Brainsway shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Brainsway has a consensus target price of $18.20, suggesting a potential upside of 33.73%. Given Brainsway's stronger consensus rating and higher possible upside, analysts clearly believe Brainsway is more favorable than Jin Medical International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Jin Medical International
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Brainsway
0 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.71

Jin Medical International has a beta of 7.31, indicating that its share price is 631% more volatile than the broader market. Comparatively, Brainsway has a beta of 1.25, indicating that its share price is 25% more volatile than the broader market.

Brainsway has higher revenue and earnings than Jin Medical International.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Jin Medical International$20.69M7.54$1.19MN/AN/A
Brainsway$52.22M10.48$7.57M$0.4430.93

Brainsway has a net margin of 15.65% compared to Jin Medical International's net margin of 0.00%. Brainsway's return on equity of 12.74% beat Jin Medical International's return on equity.

Company Net Margins Return on Equity Return on Assets
Jin Medical InternationalN/A N/A N/A
Brainsway 15.65%12.74%8.17%

Summary

Brainsway beats Jin Medical International on 13 of the 14 factors compared between the two stocks.

How does Jin Medical International compare to Tactile Systems Technology?

Jin Medical International (NASDAQ:ZJYL) and Tactile Systems Technology (NASDAQ:TCMD) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, analyst recommendations, media sentiment, earnings, risk, valuation and dividends.

Tactile Systems Technology has a consensus target price of $38.40, suggesting a potential upside of 72.97%. Given Tactile Systems Technology's stronger consensus rating and higher probable upside, analysts plainly believe Tactile Systems Technology is more favorable than Jin Medical International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Jin Medical International
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Tactile Systems Technology
0 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.67

In the previous week, Tactile Systems Technology's average media sentiment score of 0.00 beat Jin Medical International's score of -0.25 indicating that Tactile Systems Technology is being referred to more favorably in the news media.

Company Overall Sentiment
Jin Medical International Neutral
Tactile Systems Technology Neutral

83.4% of Tactile Systems Technology shares are held by institutional investors. 2.1% of Tactile Systems Technology shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Tactile Systems Technology has a net margin of 7.10% compared to Jin Medical International's net margin of 0.00%. Tactile Systems Technology's return on equity of 11.49% beat Jin Medical International's return on equity.

Company Net Margins Return on Equity Return on Assets
Jin Medical InternationalN/A N/A N/A
Tactile Systems Technology 7.10%11.49%9.17%

Tactile Systems Technology has higher revenue and earnings than Jin Medical International.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Jin Medical International$20.69M7.54$1.19MN/AN/A
Tactile Systems Technology$329.52M1.53$19.09M$1.0820.56

Jin Medical International has a beta of 7.31, indicating that its share price is 631% more volatile than the broader market. Comparatively, Tactile Systems Technology has a beta of 0.8, indicating that its share price is 20% less volatile than the broader market.

Summary

Tactile Systems Technology beats Jin Medical International on 11 of the 13 factors compared between the two stocks.

How does Jin Medical International compare to NeuroPace?

Jin Medical International (NASDAQ:ZJYL) and NeuroPace (NASDAQ:NPCE) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, profitability, earnings, analyst recommendations, valuation, institutional ownership, media sentiment and risk.

Jin Medical International has a net margin of 0.00% compared to NeuroPace's net margin of -19.34%. Jin Medical International's return on equity of 0.00% beat NeuroPace's return on equity.

Company Net Margins Return on Equity Return on Assets
Jin Medical InternationalN/A N/A N/A
NeuroPace -19.34%-105.64%-16.51%

78.8% of NeuroPace shares are owned by institutional investors. 19.2% of NeuroPace shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Jin Medical International has higher earnings, but lower revenue than NeuroPace.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Jin Medical International$20.69M7.54$1.19MN/AN/A
NeuroPace$99.99M4.90-$21.47M-$0.57N/A

NeuroPace has a consensus target price of $19.33, suggesting a potential upside of 35.39%. Given NeuroPace's stronger consensus rating and higher probable upside, analysts clearly believe NeuroPace is more favorable than Jin Medical International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Jin Medical International
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
NeuroPace
1 Sell rating(s)
1 Hold rating(s)
6 Buy rating(s)
2 Strong Buy rating(s)
2.90

In the previous week, NeuroPace had 3 more articles in the media than Jin Medical International. MarketBeat recorded 3 mentions for NeuroPace and 0 mentions for Jin Medical International. NeuroPace's average media sentiment score of 0.47 beat Jin Medical International's score of -0.25 indicating that NeuroPace is being referred to more favorably in the news media.

Company Overall Sentiment
Jin Medical International Neutral
NeuroPace Neutral

Jin Medical International has a beta of 7.31, meaning that its share price is 631% more volatile than the broader market. Comparatively, NeuroPace has a beta of 1.94, meaning that its share price is 94% more volatile than the broader market.

Summary

NeuroPace beats Jin Medical International on 9 of the 15 factors compared between the two stocks.

How does Jin Medical International compare to Sight Sciences?

Jin Medical International (NASDAQ:ZJYL) and Sight Sciences (NASDAQ:SGHT) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, media sentiment, earnings, analyst recommendations, dividends, institutional ownership, valuation and risk.

Jin Medical International has a beta of 7.31, meaning that its stock price is 631% more volatile than the broader market. Comparatively, Sight Sciences has a beta of 2.5, meaning that its stock price is 150% more volatile than the broader market.

Jin Medical International has higher earnings, but lower revenue than Sight Sciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Jin Medical International$20.69M7.54$1.19MN/AN/A
Sight Sciences$77.36M5.71-$38.43M-$0.56N/A

Jin Medical International has a net margin of 0.00% compared to Sight Sciences' net margin of -35.69%. Jin Medical International's return on equity of 0.00% beat Sight Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Jin Medical InternationalN/A N/A N/A
Sight Sciences -35.69%-43.39%-22.86%

55.5% of Sight Sciences shares are held by institutional investors. 30.4% of Sight Sciences shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Sight Sciences has a consensus price target of $7.88, suggesting a potential downside of 1.81%. Given Sight Sciences' stronger consensus rating and higher probable upside, analysts plainly believe Sight Sciences is more favorable than Jin Medical International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Jin Medical International
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Sight Sciences
1 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.50

In the previous week, Sight Sciences had 4 more articles in the media than Jin Medical International. MarketBeat recorded 4 mentions for Sight Sciences and 0 mentions for Jin Medical International. Sight Sciences' average media sentiment score of 0.26 beat Jin Medical International's score of -0.25 indicating that Sight Sciences is being referred to more favorably in the news media.

Company Overall Sentiment
Jin Medical International Neutral
Sight Sciences Neutral

Summary

Sight Sciences beats Jin Medical International on 8 of the 14 factors compared between the two stocks.

Get Jin Medical International News Delivered to You Automatically

Sign up to receive the latest news and ratings for ZJYL and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ZJYL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ZJYL vs. The Competition

Export
MetricJin Medical InternationalHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$156.08M$5.55B$7.24B$13.19B
Dividend YieldN/A1.80%2.57%12.81%
P/E RatioN/A25.34275.4925.40
Price / Sales7.5472.49646.0189.45
Price / Cash10.8632.6476.2551.42
Price / Book0.535.6910.466.33
Net Income$1.19M$151.55M$3.49B$358.33M
7 Day Performance-3.86%0.66%0.59%1.12%
1 Month Performance-34.32%-3.33%-1.74%-2.39%
1 Year Performance-82.52%6.79%18.13%5.35%

Jin Medical International Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ZJYL
Jin Medical International
0.8899 of 5 stars		$1.99
+0.5%		N/A-82.5%$156.08M$20.69MN/A273
DCTH
Delcath Systems
2.783 of 5 stars		$16.38
+1.3%		$23.17
+41.4%		+39.6%$570.12M$85.23M1,644.64156
BWAY
Brainsway
4.6423 of 5 stars		$13.44
-0.2%		$18.20
+35.4%		+76.0%$540.95M$52.22M30.58129
TCMD
Tactile Systems Technology
3.3292 of 5 stars		$22.57
+0.2%		$38.40
+70.2%		+57.9%$510.19M$329.52M20.861,086
NPCE
NeuroPace
3.2186 of 5 stars		$14.26
+0.1%		$19.50
+36.7%		+43.7%$491.12M$99.99MN/A220

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:ZJYL) was last updated on 9/20/2026 by MarketBeat.com Staff.
From Our Partners
“Elon’s nightmare” could fund your retirement
Marc Chaikin, the 60 year Wall Street veteran whose Chaikin Money Flow indicator sits on every Bloomberg termi...
Chaikin Analytics | Sponsoredtc pixel
You’ve never seen anything like this before
For centuries, families like the Rothschilds, Morgans, and Rockefellers have quietly used one overlooked type ...
Porter & Company | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
NVDA CEO says it’s a "once-in-a-generation opportunity"
NVIDIA CEO Jensen Huang calls a little-known AI niche a once-in-a-generation opportunity, and it has nothing t...
Monument Traders Alliance | Sponsoredtc pixel
Trump goes "all-in" on Grand Canyon energy breakthrough
A drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of...
Behind the Markets | Sponsoredtc pixel
A “bloodbath” Is Coming
Reports suggest some Silicon Valley billionaires are stockpiling gold, guns, and gas masks - or leaving the co...
TradeSmith | Sponsoredtc pixel
The hidden costs of a hands-off retirement account
Contributing to your 401(k) consistently is good financial behavior - but contributing and optimizing are two ...
SmartAsset | Sponsoredtc pixel